Position in CGC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,038
-$1,019,630 QoQ
Shares Held
3,203
-99.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Dec 31, 2024CallValue
$274,000
CallShares
100,000
PutValue
$140,288
PutShares
51,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. CGC ranks #48 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
639,372 | $13,273,362 |
All Filings in CGC
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,038 | 3,203 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,022,668 | 897,078 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $23,656 | 16,203 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $23,183 | 19,003 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $15,017 | 16,503 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $274,000 | 100,000 | Call | Sole | 2026-03-19 | |
| 2024-12-31 | $140,288 | 51,200 | Put | Sole | 2026-03-19 | |
| 2024-12-31 | $140,296 | 51,203 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $14 | 3 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $19 | 3 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $236,832 | 27,443 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $57,947 | 11,340 | Shares | Sole | 2026-03-24 | |
| No filing history on record for this holder in this stock. | ||||||